INTERNATIONAL PATENT: DISPATCH BIOTHERAPEUTICS, INC. FILES APPLICATION FOR "MODIFIED LENTIVIRAL TRANSFER PLASMIDS"

GENEVA, Nov. 25 -- DISPATCH BIOTHERAPEUTICS, INC. (25 N 38th St., Floor 6Philadelphia, Pennsylvania 19104) filed a patent application (PCT/US2025/029200) for "MODIFIED LENTIVIRAL TRANSFER PLASMIDS" on May 13, 2025. With publication no. WO/2025/240518, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIU, Raymond (c/o Dispatch Biotherapeutics, Inc.25 N 38th St., Floor 6Philadelphia, Pennsylvania 19104), TAFT, Justin (c/o Dispatch Biotherapeutics, Inc.25 N 38th St., Floor 6Philadelphia, Pennsylvania 19104), JOHNSON, Lexus R....